Skip to main content

ERRATUM article

Front. Immunol., 27 September 2023
Sec. Cancer Immunity and Immunotherapy
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1297519
This article is part of the Research Topic Reciprocal Crosstalk Between the Tumor Microenvironment and Cancer Stem Cells View all 6 articles

Erratum: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment

This article is an erratum on:

  1. IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment

    1. Read original article
Frontiers Production Office* Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment

by Elcheva IA, Gowda CP, Bogush D, Gornostaeva S, Fakhardo A, Sheth N, Kokolus KM, Sharma A, Dovat S, Uzun Y, Schell TD and Spiegelman VS (2023) Front. Immunol. 14:1224516. doi: 10.3389/fimmu.2023.1224516

Due to a production error, an incorrect Data Availability statement was provided. The correct Data Availability statement appears below.

“The original contributions presented in the study are publicly available. This data can be found here: GEO database, accession number GSE236818”.

The publisher apologizes for this mistake.

The original version of this article has been updated.

Keywords: IGF2BP/IMP, RNA-binding protein (RBP), interferon-stimulated genes (ISGs), melanoma, leukemia, anti-PD-1, immunotherapy, cancer stem cell (CSC)

Citation: Frontiers Production Office (2023) Erratum: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment. Front. Immunol. 14:1297519. doi: 10.3389/fimmu.2023.1297519

Received: 20 September 2023; Accepted: 20 September 2023;
Published: 27 September 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.